Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for AVNS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2014. Start Trial.
Date Value
May 31, 2026 81.48%
April 30, 2026 81.48%
March 31, 2026 81.48%
February 28, 2026 81.48%
January 31, 2026 81.48%
December 31, 2025 81.48%
November 30, 2025 81.48%
October 31, 2025 81.48%
September 30, 2025 81.48%
August 31, 2025 81.48%
July 31, 2025 79.08%
June 30, 2025 77.47%
May 31, 2025 77.47%
April 30, 2025 77.47%
March 31, 2025 73.88%
February 28, 2025 72.64%
January 31, 2025 72.64%
December 31, 2024 72.64%
November 30, 2024 72.64%
October 31, 2024 72.64%
September 30, 2024 72.64%
August 31, 2024 72.64%
July 31, 2024 72.64%
June 30, 2024 72.64%
May 31, 2024 72.64%
Date Value
April 30, 2024 72.64%
March 31, 2024 72.64%
February 29, 2024 72.64%
January 31, 2024 72.64%
December 31, 2023 72.64%
November 30, 2023 72.64%
October 31, 2023 72.64%
September 30, 2023 72.64%
August 31, 2023 72.64%
July 31, 2023 72.64%
June 30, 2023 72.64%
May 31, 2023 72.64%
April 30, 2023 72.64%
March 31, 2023 72.64%
February 28, 2023 72.64%
January 31, 2023 72.64%
December 31, 2022 72.64%
November 30, 2022 72.64%
October 31, 2022 72.64%
September 30, 2022 71.59%
August 31, 2022 71.59%
July 31, 2022 71.59%
June 30, 2022 71.59%
May 31, 2022 71.59%
April 30, 2022 71.59%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Boston Scientific Corp. 55.33%
Embecta Corp. --
Abbott Laboratories 39.63%
AngioDynamics, Inc. 82.98%
Alphatec Holdings, Inc. 73.51%